The "vicious circle" of thyroid metabolism in patients with chronic kidney disease
https://doi.org/10.36485/1561-6274-2021-25-1-76-82
Abstract
Background. Decreased thyroid function is common in patients with chronic kidney disease. Under conditions of hypothyroidism, there is significant changes in lipid metabolism, nitrogen excretion function of the kidneys. THE AIM. To study the parameters of the functional state of the thyroid gland in patients with various stages of chronic kidney disease.
Patients and methods. A one-stage cross-sectional study of patients with glomerulopathies without clinically significant diseases of the cardiovascular system with preserved EF (> 55 % according to Simpson) from April 2019 to March 2020 was carried out. The study included 270 patients. To identify subclinical hypothyroidism (SH), the TSH level was determined. Patients were divided into groups according to TSH level: low TSH, normal TSH, and subclinical hypothyroidism. In patients, the indicators of biochemical blood analysis, data from a complex laboratory functional examination of the kidneys were assessed.
Results. The detection rate of SH in patients with different stages of CKD was 17.56 %. Patients with SH were significantly older than the group of patients with normal TSH levels (p=0.002). In the group of patients with subclinical hypothyroidism, anti-TPO antibodies were detected only in 9.6 % of patients. A correlation was found between GFR and free T3 in patients with 3B and 4 stages of CKD (r=0.3, p<0.05). In the group of patients with subclinical hypothyroidism, there was a decrease in total protein and albumin, an increase in daily proteinuria, a decrease in total calcium, increased inorganic phosphorus, chlorine, decreased renal transport of uric acid.
Conclusion. Increased TSH levels are associated with advanced stages of CKD. The increase in TSH levels in patients with CKD is not associated with female sex and older age. In most patients with glomerulopathies, an increase in TSH levels is not an outcome of autoimmune thyroiditis. SH in CKD patients is associated with severe impairment of renal nitrogen excretion function, protein, and electrolyte metabolism.
About the Authors
A. R. VolkovaRussian Federation
Volkova Anna Ralfovna - Department of Faculty Therapy, Professor.
197022, St. Petersburg, L'va Tolstogo str. 6-8, Phone: +7-921-33429-63
I. M. Abramova
Russian Federation
Abramova Inna Mikhailovna - Department of Faculty Therapy, Postgraduate.
197022, St. Petersburg, L'va Tolstogo str. 6-8, Phone: +7950-006-29-40
G. G. Allamova
Russian Federation
Allamova Gulbahar Gurbanbaevna - Department of Faculty Therapy, Postgraduate.
197022, St. Petersburg, L'va Tolstogo str. 6-8, Phone: +7-981964-84-63
M. S. Khrabrova
Russian Federation
Khrabrova Maria Sergeevna - Department of Propaedeutics of Internal Diseases, Assistant Professor.
197022, St. Petersburg, L'va Tolstogo str. 6-8, Phone: +7 (812) 338-69-01
O. D. Dygun
Russian Federation
Dygun Olga Dmitrievna - Department of Faculty Therapy, Assistant.
197022, St. Petersburg, L'va Tolstogo str. 6-8, Phone: +7-965-79711-79
References
1. Rhee CM, Kalantar-Zadeh K, Brent GA, eds. Endocrine Disorders in kidney disease. Diagnosis and Treatment. Springe, Cham, 2019;85-109. doi: 10.1007/978-3-319-97765-2
2. Rhee CM, Kalantar-Zadeh K, Streja E et al. The relationship between thyroid function and estimated glomerular filtration rate in patients with chronic kidney disease. Nephrol Dial Transplant 2015;30:282-287. doi: 10.1093/ndt/gfu303
3. Chuang M-H, Liao K-M, Hung Y-M et al. Abnormal ThyroidStimulating Hormone and Chronic Kidney Disease in Elderly Adults in Taipei City. J Am Geriatr Soc 2016; 64:1267-1273. doi:10.1111/jgs.14102
4. Chandra A. Prevalence of hypothyroidism in patients with chronic kidney disease: a cross-sectional study from North India. Kidney Res Clin Pract 2016;35:165-168. doi: 10.1016/j.krcp.2016.06.003
5. Rhee CM. Abnormalities of Thyroid Function in Chronic Dialysis Patients. In: Nissenson AR, Fine RN, eds. Handbook of Dialysis Therapy, 5th ed. Elsevier, 2017; 660-673.e4. doi: 10.1016/C2014-0-03172-3
6. Surks MI, Hollowell JG. Age-specific distribution of serum thyrotropin and antithyroid antibodies in the U.S. population: Implications for the prevalence of subclinical hypothyroidism. J Clin Endocrinol Metab 2007;92(12):4575-4582
7. Lo JC, Chertow GM, Go AS et al. Increased prevalence of subclinical and clinical hypothyroidism in persons with chronic kidney disease. Kidney Int 2005;67:1047-1052. doi:10.1111/j.1523-1755.2005.00169.x
8. Kettail VM, Arki RA. Pathophysiology of the endocrine system. BINOM Publishers 2001;66 (In Russ.)
9. Suher M, Koc E, Ata N et al. Relation of thyroid disfunction, thyroid autoantibodies, and renal function. Ren Fail 2005;27:739-742
10. Smirnov AV, Shilov EM, Dobronravov VA et al. National guidelines. Chronic kidney disease: basic principles of screening, diagnosis, prevention and treatment approaches. Clinical nephrology 2012; 4: 4-26
11. Fadeev VV. Comments to guidelines for the treatment of hypothyroidism prepared by the American thyroid association task force on thyroid hormone replacement. Clinical and experimental thyroidology 2012; 8: 9-16. doi: 10.4158/EP12280.GL
12. Hak AE, Pols HA, Visser TJ et al. Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study. Ann Intern Med 2000;132:270-278
13. Faber J, Heaf J, Kirkegaard C et al. Simultaneous turnover studies of thyroxine, 3,5,3’ and 3,3’,5’-triiodothyronine, 3,5-, 3,3’-, and 3’,5’- diiodothyronine, and 3’-monoiodothyronine in chronic renal failure. J Clin Endocrinol Metab 1983;56:211-217. doi: 10.1210/jcem-56-2-211
14. Jain D, Haddad DB, Goel N. Choice of dialysis modality prior to kidney transplantation: does it matter? World J Nephrol 2019;8(1):1-10. doi: 10.5527/wjn.v8.i1.1
15. Fan J, Yan P, Wang Y et al. Prevalence and clinical significance of low T3 syndrome in non-dialysis patients with chronic kidney disease. Med Sci Monit 2016;22:1171-1179. doi: 10.12659/msm.895953
16. Volkova AR, Dygun OD, Lukichev BG et al. Thyroid dysfunction in patients with chronic kidney disease: the state of the problem and the ways of solving. Nephrology 2018;22(4): 40-49. doi:10.24884/1561-6274-2018-22-4-40-49. (In Russ.)
17. Sanai T, Okamura K, Rikitake S et al. The high prevalence of reversible subclinical hypothyroidism with elevated serum thyroglobulin levels in chronic kidney disease patients. Clin Nephrol 2017;87(5):237-244. doi: 10.5414/CN109008
18. Sazonova EG, Mohort TV. Thyroid function in diabetes complicated by chronic kidney disease. International Journal of Endocrinology 2013;50(2):62-67. (In Russ.)
19. Orlova MM, Rodionova TI. The state of renal function in patients with hypothyroidism (review). Medical Almanac 2010;12(3):112-114. (In Russ.)
20. Troshina EA, Abdulkhabirova FM. Euthyroid sick syndrome. Problems of Endocrinology 2001; 47(6):34-36. (InRuss.)
21. Inozemsteva MP, Inosemstev PV, Panova TN. The estimation of thyroid status in patients with chronic renal insufficiency. Astrakhan Medical Journal 2011;6(3):83-85. (InRuss.)
22. Volkova AR, Krasilnikova EI, Berkovich OA et al. Thyroid gland function, smoking, and cardiovascular risk in heart ischemic disease patients. The Scientific Notes of the Pavlov University 2010;17(2):17-21. (In Russ.)
23. Iglesias P, Diez JJ. Thyroid dysfunction and kidney disease. Eur J Endocrinol 2009;160(4):503-515. doi: 10.1530/eje-08-0837
24. Ahi S, Amouzegar A, Gharibzadeh S et al. Trend of lipid and thyroid function tests in adults without overt thyroid diseases: A cohort from Tehran thyroid study. PLOS ONE 2019; 14(5): e0216389. doi: 10.1371/journal.pone.0216389
Review
For citations:
Volkova A.R., Abramova I.M., Allamova G.G., Khrabrova M.S., Dygun O.D. The "vicious circle" of thyroid metabolism in patients with chronic kidney disease. Nephrology (Saint-Petersburg). 2021;25(1):76-82. (In Russ.) https://doi.org/10.36485/1561-6274-2021-25-1-76-82